BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, January 5, 2026
Home » Topics » Science

Science
Science RSS Feed RSS

Vaccination
Vaccine durability

Thanks for the memories, but could you make them less selective?

Aug. 28, 2020
By Anette Breindl
With COVID-19, questions about how infections cause lasting immunity, or don’t, and how you know and what it all means for vaccines have become a matter of public focus. But some immunologists have been pondering those questions for years. “The immune system has a very good memory,” Bali Pulendran told BioWorld. “Clearly, some viruses and some pathogens can enter the body and stimulate the immune system, and the immune system can remember that encounter for decades.”
Read More

BioWorld MedTech’s Neurology Extra for Aug. 28, 2020

Aug. 28, 2020
By Andrea Applegate
Keeping you up to date on recent developments in neurology, including: Blood-based test used to predict who is likely to develop psychotic disorders; Study could lead to more personalized choices for OCD treatment; Nerve cells differ before birth in people with ASD.
Read More
Cancer cell

Bench Press for Aug. 28, 2020

Aug. 28, 2020
BioWorld looks at translational medicine, including: iBET you I can kill those metastases; Elite controller achieves none-in-a-billion status; AP-1 and antidepressant action; ‘Undruggable’ phosphatase can be targeted for dystrophies; Candida auris: mostly, nothing wrong; In T cells, exhaustion starts young; Chewing the fat keeps stem cells quiet; Antiviral protein produces flu mRNAs; Engineered brown fat cells improve blood sugar control; For organs, rejuvenation helps transplantation.
Read More

BioWorld MedTech’s Diagnostics Extra for Aug. 27, 2020

Aug. 27, 2020
By Meg Bryant and Anette Breindl
Keeping you up to date on recent developments in diagnostics, including: A.I. tool promises faster, more accurate Alzheimer's diagnosis; Bioluminescent tool tracks DNA break repair; Mechanisms of retinopathy come into focus.
Read More

BioWorld MedTech’s Orthopedics Extra for Aug. 26, 2020

Aug. 26, 2020
By Holland Johnson
Keeping you up to date on recent developments in orthopedics, including: Hip fracture risk linked to nanoscale bone inflexibility; High intensity physical activity in early life could lead to stronger bones in adulthood; Xtant Medical reports U.S. launch of the Matriform Si; Opioid prescription rates for knee surgery vary, but higher strength dosage common.
Read More
Petri dish and capsules

Singapore-based researchers find a SMART way to reduce bacterial antibiotic resistance

Aug. 25, 2020
By David Ho
HONG KONG – Researchers from the Massachusetts Institute of Technology’s (MIT) research enterprise in Singapore have found a way to not just reverse antibiotic resistance but also increase sensitivity in some bacteria, using hydrogen sulfide.
Read More

BioWorld MedTech’s Oncology Extra for Aug. 25, 2020

Aug. 25, 2020
By Mark McCarty and Anette Breindl
Keeping you up to date on recent developments in oncology, including: Microspheres paired with LHRH perform well in study of triple-negative breast cancer; New partner in crime for AHR; MMA induces epithelial-to-mesenchymal transition; SCCA incidence trending up in U.S.
Read More

BioWorld MedTech’s Cardiology Extra for Aug. 24, 2020

Aug. 24, 2020
By Liz Hollis
Keeping you up to date on recent developments in cardiology, including: Deep chest compressions help save brain; Selfies for heart disease?; Looking to the past to understand the heart.
Read More
Reinfection illustration
Second infection asymptomatic

Case study brings strongest evidence yet for COVID-19 reinfection

Aug. 24, 2020
By Anette Breindl
Through the use of sequencing data, researchers in Hong Kong presented a case study providing the strongest evidence yet that individuals can become reinfected with SARS-CoV-2 after clearing a first infection.
Read More
Microscope

Abandonment of coronavirus research after outbreaks hampers preparedness

Aug. 21, 2020
By Annette Boyle
Despite two significant coronavirus outbreaks in the last two decades that killed hundreds of people, dominated international headlines, and grabbed millions in research dollars, SARS-CoV-2 still caught researchers, national scientific advisors, pharmaceutical companies flatfooted when it emerged in late 2019. Why?
Read More
Previous 1 2 … 136 137 138 139 140 141 142 143 144 … 188 189 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Jan 5, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Jan. 5, 2026.
  • Sickle cell illustration

    AND-017 increases RBC and hemoglobin in sickle cell disease

    BioWorld Science
    Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
  • Businessman, businesswoman handshake

    Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact

    BioWorld
    Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
  • 3D rendering of antibody drug conjugated with cytotoxic payload

    ADCs’ breakout 2025 and their still-unfinished potential

    BioWorld Science
    Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing